Half-year report · Q2
2503.TEDINET S100WHH8
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.14T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.34T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.10T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥68.7bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥80.9bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥83.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥139.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥108.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥52.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥58.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥57.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥60.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥74.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.30T | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥3.35T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.13T | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.89T | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.82T | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.41T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.53T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.59T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.12T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.18T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.29T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥132.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥138.4bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥67.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥242.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥108.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥61.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥329.4bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥116.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥35.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥58.1bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥21.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥65.23 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥71.87 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥65.22 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥71.86 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 34.0% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 35.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥47.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥14.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥32.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | −¥591m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥30.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥493.8bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥492.6bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥53.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥129.7bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥127.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥273.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥271.8bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥29.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥230.7bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥230.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥156m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥33.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥45.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥34.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥331m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥26.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥513.7bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥512.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥50.3bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥71.1bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥69.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥270.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30.1bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥233.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥232.8bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥132m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥41.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 858
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1738 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 55382000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0682 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 31346000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0386 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 29983000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0369 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 17049000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0210 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 16097000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0198 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 15264000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0188 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 10412000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0128 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 9620000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0118 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 9269000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0114 | |
| Number of shares held | CurrentQuarterInstant | 335535000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4133 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 102248500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 8098522 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 809852200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1899300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 914000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 8098522 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 102248500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 102248500 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1118 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 102248500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 102248500 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1118 | |
| Property plant and equipment IFRS | Prior1YearInstant | 674028000000 | JPY |
| Property plant and equipment IFRS | CurrentQuarterInstant | 683730000000 | JPY |
| Goodwill IFRS | Prior1YearInstant | 501480000000 | JPY |
| Goodwill IFRS | CurrentQuarterInstant | 483946000000 | JPY |
| Intangible assets IFRS | Prior1YearInstant | 659561000000 | JPY |
| Intangible assets IFRS | CurrentQuarterInstant | 642591000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant | 216205000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentQuarterInstant | 224443000000 | JPY |
| Other financial assets nca IFRS | Prior1YearInstant | 103360000000 | JPY |
| Other financial assets nca IFRS | CurrentQuarterInstant | 107361000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 48570000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |